Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Total Hip Arthroplasty in a Low-Income Country
oleh: Simon Matthew Graham, MBChB, MRCS, MSc(Res), FRCS, Nicholas Howard, MBChB, MRCS, MSc, FRCS, Chipiliro Moffat, Nicholas Lubega, MBChB, MMed(Ortho), FCS(ECSA), MBA, Nyengo Mkandawire, BMBS, FRCS, MCh(Orth), FCS(ECSA), William J. Harrison, MA(Oxon), FRCS(Tr&Orth)
| Format: | Article |
|---|---|
| Diterbitkan: | Wolters Kluwer 2019-12-01 |
Deskripsi
Background:. We describe our 10-year experience performing total hip arthroplasty (THA) in patients enrolled in the National Joint Registry of the Malawi Orthopaedic Association. Methods:. Eighty-three THAs were performed in 70 patients (40 male and 30 female) with a mean age of 52 years (range, 18 to 77 years). The cohort included 24 patients (14 male and 10 female; mean age, 52 years [range, 35 to 78 years]) who were human immunodeficiency virus (HIV)-positive. Results:. The main indications for surgery were osteonecrosis (n = 41 hips) and osteoarthritis (n = 26 hips). There were no deaths perioperatively and no early complications at 6 weeks. Forty-six patients (59 THAs) were seen at 10 years postoperatively, with a mean Harris hip score (HHS) of 88 (range, 41 to 91) and a mean Oxford Hip Score (OHS) of 46 (range, 25 to 48). Five hips (8% of 59) were revised due to loosening (n = 4) and fracture (n = 1). There were no infections or dislocations. Fourteen patients died, including 4 HIV-positive patients, of unknown causes in the follow-up period, and 10 patients were lost to follow-up. In the group of 24 HIV-positive patients, there were no early complications, and the mean HHS was 88 (range, 76 to 91) at >10 years. Conclusions:. Our 10-year experience and long-term outcomes after primary THA in a low-income setting show that good results can be achieved within a controlled hospital environment, thereby establishing a benchmark against which other hospitals and registries in similar low-income countries can compare their results. Level of Evidence:. Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.